Medical Director, ADHD

Overview Tris Pharma, Inc. is a leading privately-owned U.S. biopharmaceutical company focused on development and commercialization of innovative medicines in ADHD, spectrum disorders, anxiety, pain and addiction addressing unmet patient needs. We have >150 US and international patents and market several branded ADHD products in the U.S. We license our products in the US and ex-US markets. Our pipeline spans neuroscience and other therapeutic categories, employing our proprietary science and technology. Our science and technology make us unique, but our team members set us apart. We believe in respectful, open and honest communications to support individual and team success. We have an immediate opening in our Medical Affairs department in Monmouth Junction, NJ for an experienced Medical Director. The Medical Director, ADHD serves as a key leader within the medical affairs team, overseeing the medical and scientific strategy for the company’s ADHD portfolio. This role acts as the medical and scientific authority in the ADHD therapeutic area and works cross-functionally with Commercial, Regulatory, R&D, Market Access, and other internal departments. The Medical Director plays a pivotal role in planning, execution, and oversight of Phase IV/IIS trials, medical communication, and stakeholder engagement specific to ADHD. This position also serves as a senior liaison with global healthcare providers, regulatory agencies, researchers, and key opinion leaders in ADHD, contributing to strategic direction and operational excellence of the organization. Responsibilities Provides strategic leadership for the company’s ADHD product portfolio, focusing on advancing medical affairs goals in attention-deficit/hyperactivity disorder. Develops and implements comprehensive Medical Operating Plans (MOPs) in collaboration with cross-functional stakeholders, including Brand/Product Directors and Global Medical Affairs teams, tailored to ADHD indications. Leads the medical oversight and execution of company-sponsored clinical studies, including Phase IV/IIS studies in ADHD, ensuring alignment with scientific objectives and business priorities. Supervises and reviews external investigator-initiated research proposals, scientific initiatives, and dissemination strategies to ensure alignment with company ADHD goals. Acts as ADHD scientific and therapeutic area expert, supporting internal functions including commercial brand teams, regulatory affairs, and R&D. Leads organization and execution of advisory boards, investigator meetings, medical strategy forums, and internal scientific discussions focused on ADHD. Builds and maintains high-level relationships with global KOLs in ADHD, academic institutions, managed care organizations, advocacy groups, and government/regulatory bodies. Ensures compliance with Good Clinical Practice (GCP), PhRMA code, and applicable regulatory guidelines in all ADHD medical affairs activities. Supports publication strategy for ADHD data, including development of abstracts, posters, manuscripts, and congress presentations in collaboration with medical writing and communications teams. Monitors and assesses scientific and industry trends in ADHD to provide expert insights on competitive landscape and therapeutic advancements. Serve as a senior medical advisor and strategic partner across the organization on all ADHD-related matters. Qualifications MD, PhD, or PharmD with focus in Adult Psychiatry, Child/Adolescent Psychiatry, Neurology, or a closely related specialty with focus on ADHD and minimum 10 years experience in the pharmaceutical or biotechnology industry within medical affairs or clinical research in positions of increasing technical responsibility (minimum 3 of those years in ADHD) REQUIRED Proven ability to design and lead Phase IV trials and post-marketing clinical programs in ADHD REQUIRED Strong knowledge of GCP, PhRMA code, and regulatory guidelines governing post-marketing studies in neuropsychiatric disorders REQUIRED Exceptional communication and presentation skills across scientific, clinical, and commercial audiences REQUIRED Strong leadership capabilities with a proven track record of cross-functional collaboration in a matrixed organization REQUIRED Proficiency in scientific analysis, data interpretation, and statistical methods relevant to ADHD outcomes REQUIRED Demonstrated ability to manage high-level scientific relationships and represent the organization in external engagements within the ADHD community REQUIRED In-depth experience with prescription ADHD medications (stimulants and non-stimulants) PREFERRED Additional Details Travel Requirements: Approximately 20–30% global travel may be required to attend medical congresses (e.g., AACAP, APSARD, ECNP), scientific advisory boards, or regional affiliate meetings focused on ADHD. Work Arrangements: We are a HYBRID work environment requiring candidates to be able to work majority of week in our NJ office. Anticipated salary range: $200 to $220K/yr. Base salary offered is contingent on assessment of candidate’s education and experience level relative to requirements of the position and a review of related industry standards and internal equity. Additional benefits: In addition to base salary, full-time employees are also eligible for incentives, including, but not limited to: bonus eligible, medical, dental, vision, Rx insurance, 401K with match, life insurance, paid Company Holidays, PTO, Paid Volunteer Time and Employee Resource Groups. Tris Pharma, Inc. offers a highly competitive compensation and benefits package. To build and enhance our diverse workforce, we encourage applications from individuals with disabilities, minorities, veterans, women, LGBTQ, etc. Tris Pharma, Inc. is an Equal Opportunity Employer. #J-18808-Ljbffr